SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $596,000 | -36.6% | 114,437 | +0.1% | 0.02% | -22.7% |
| Q1 2022 | $940,000 | -50.6% | 114,312 | -10.6% | 0.02% | -45.0% |
| Q4 2021 | $1,904,000 | -23.5% | 127,925 | -2.9% | 0.04% | -28.6% |
| Q3 2021 | $2,490,000 | +1.3% | 131,792 | -0.3% | 0.06% | +5.7% |
| Q2 2021 | $2,457,000 | -23.6% | 132,174 | -6.5% | 0.05% | -18.5% |
| Q1 2021 | $3,216,000 | -1.4% | 141,290 | -6.0% | 0.06% | -12.2% |
| Q4 2020 | $3,263,000 | – | 150,283 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |